SEARCH

SEARCH BY CITATION

References

  • Adams IB, Compton DR, Martin BR (1998). Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 284: 12091217.
  • Bliss CI (1967). Statistics in Biology: Statistical Methods for Research in the Natural Sciences. McGraw-Hill: New York.
  • Breivogel CS, Griffin G, Di Marzo V, Martin BR (2001). Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol Pharmacol 60: 155163.
  • Cheng Y-C, Prusoff WH (1973). Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22: 30993108.
  • Compton DR, Aceto MD, Lowe J, Martin BR (1996). In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of Δ9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277: 586594.
  • Compton DR, Johnson MR, Melvin LS, Martin BR (1992). Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. J Pharmacol Exp Ther 260: 201209.
  • Compton DR, Rice KC, de Costa BR, Razdan RK, Melvin LS, Johnson MR et al. (1993). Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265: 218226.
  • D'Amour FE, Smith DL (1941). A method for determining loss of pain sensation. J Pharmacol Exp Ther 72: 7479.
  • Dewey WL (1986). Cannabinoid Pharmacology. Pharmacol Rev 38: 151178.
  • Gill EW, Paton WDM, Pertwee RG (1970). Preliminary experiments on the chemistry and pharmacology of cannabis. Nature 228: 134136.
  • Harvey DJ, Brown NK (1988). Metabolism of delta-8- and delta-9-tetrahydrocannabinol homologues in mice. In Chesher G, Consroe P, Musty R (eds). Marijuana: An International Research Report, Monograph Series No. 7. Australian Gov. Publ. Service: Canberra, Australia, pp. 253258.
  • Hollister LE (1974). Structure-activity relationships in man of cannabis constituents and homologs and metabolites of Δ9-tetrahydrocannabinol. Pharmacology 11: 311.
  • Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA et al. (2002). International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors. Pharmacol Rev 54: 161202.
  • Kurkinen KMA, Koistinaho J, Laitinen JT (1997). [γ-35S]GTP autoradiography allows region-specific detection of muscarinic receptor-dependent G-protein activation in the chick optic tectum. Brain Res 769: 2128.
  • Ledent C, Valverde O, Cossu G, Petitet F, Aubert J-F, Beslot F et al. (1999). Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283: 401404.
  • Pertwee RG (1972). The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice. Br J Pharmacol 46: 753763.
  • Pertwee RG (1985). Effects of cannabinoids on thermoregulation: a brief review. In: Harvey DJ (ed). Marihuana ‘84. IRL Press: Oxford, pp. 263277.
  • Pertwee RG (2001). Cannabinoids and the gastrointestinal tract. Gut 48: 859867.
  • Pertwee RG, Fernando SR, Griffin G, Ryan W, Razdan RK, Compton DR et al. (1996). Agonist-antagonist characterization of 6′-cyanohex-2′-yne-Δ8-tetrahydrocannabinol in two isolated tissue preparations. Eur J Pharmacol 315: 195201.
  • Pertwee RG, Griffin G, Lainton JAH, Huffman JW (1995). Pharmacological characterization of three novel cannabinoid receptor agonists in the mouse isolated vas deferens. Eur J Pharmacol 284: 241247.
  • Pertwee RG, Ross RA, Craib SJ, Thomas A (2002). Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens. Eur J Pharmacol 456: 99106.
  • Ross RA, Brockie HC, Stevenson LA, Murphy VL, Templeton F, Makriyannis A et al. (1999a). Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630. Br J Pharmacol 126: 665672.
  • Ross RA, Gibson TM, Stevenson LA, Saha B, Crocker P, Razdan RK et al. (1999b). Structural determinants of the partial agonist-inverse agonist properties of 6′-azidohex-2′-yne-Δ8-tetrahydrocannabinol at cannabinoid receptors. Br J Pharmacol 128: 735743.
  • Sañudo-Peña MC, Romero J, Seale GE, Fernández-Ruiz JJ, Walker JM (2000). Activational role of cannabinoids on movement. Eur J Pharmacol 391: 269274.
  • Sulcova E, Mechoulam R, Fride E (1998). Biphasic effects of anandamide. Pharmacol Biochem Behav 59: 347352.
  • Thomas A, Ross RA, Saha B, Mahadevan A, Razdan RK, Pertwee RG (2004). 6′′-Azidohex-2′′-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist. Eur J Pharmacol 487: 213221.
  • Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA et al. (2005). Evidence that the plant cannabinoid Δ9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Br J Pharmacol 146: 917926.
  • Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K et al. (2005). Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310: 329332.
  • Varvel SA, Bridgen DT, Tao Q, Thomas BF, Martin BR, Lichtman AH (2005). Δ9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice. J Pharmacol Exp Ther 314: 329337.
  • Wiley JL, Jefferson RG, Griffin G, Liddle J, Yu S, Huffman JW, Martin BR (2002). Paradoxical pharmacological effects of deoxy-tetrahydrocannabinol analogs lacking high CB1 receptor affinity. Pharmacology 66: 8999.
  • Wiley JL, Martin BR (2003). Cannabinoid pharmacological properties common to other centrally acting drugs. Eur J Pharmacol 471: 185193.
  • Wilson RS, May EL (1975). Analgesic properties of the tetrahydrocannabinols, their metabolites and analogs. J Med Chem 18: 700703.
  • Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, Bonner TI (1999). Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96: 57805785.